Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula (bilateral)
ICD-10 E09.3523 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula (bilateral).
E09.3523 refers to diabetes mellitus that is induced by drugs or chemicals, leading to significant complications such as proliferative diabetic retinopathy (PDR) and traction retinal detachment involving the macula on both sides. Drug-induced diabetes can occur due to various medications, including glucocorticoids, antipsychotics, and certain chemotherapeutic agents. Proliferative diabetic retinopathy is characterized by the growth of new blood vessels in the retina, which can lead to severe vision impairment. The presence of traction retinal detachment indicates that these new vessels are pulling on the retina, causing it to detach from the underlying tissue, particularly affecting the macula, which is crucial for central vision. Management of this condition requires careful monitoring of blood glucose levels, often necessitating insulin therapy, and regular ophthalmologic evaluations to prevent further vision loss.
Detailed medication history, HbA1c levels, and management plans.
Patients presenting with new-onset diabetes after starting a new medication.
Ensure clear documentation of the drug responsible for diabetes and its management.
Comprehensive eye exam findings, including retinal imaging results.
Patients with diabetes presenting with vision changes or retinal findings.
Document the extent of retinal detachment and any interventions performed.
Used for routine eye exams in patients with diabetes.
Document visual acuity, fundoscopic findings, and any interventions.
Ophthalmologists should ensure detailed documentation of retinal findings.
Medications such as glucocorticoids, certain antipsychotics, and some antiretrovirals are known to potentially induce diabetes by affecting insulin sensitivity or secretion.
